• 3579 Citations
  • 23 h-Index
1988 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1988 2019

  • 3579 Citations
  • 23 h-Index
  • 110 Article
  • 1 Letter
  • 1 Review article
2019

Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations

Girmenia, C., Cavo, M., Offidani, M., Scaglione, F., Corso, A., Di Raimondo, F., Musto, P., Petrucci, M. T. & Barosi, G., Jan 1 2019, (Accepted/In press) In : Blood Reviews.

Research output: Contribution to journalArticle

Multiple Myeloma
Literature
Proteasome Inhibitors
Passive Immunization
Intravenous Immunoglobulins

Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations

Girmenia, C., Cavo, M., Offidani, M., Scaglione, F., Corso, A., Di Raimondo, F., Musto, P., Petrucci, M. T. & Barosi, G., Mar 2019, In : Blood Reviews. 34, p. 84-94 11 p.

Research output: Contribution to journalReview article

Multiple Myeloma
Literature
Proteasome Inhibitors
Passive Immunization
Intravenous Immunoglobulins

Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice

Cocito, F., Mangiacavalli, S., Valeria Ferretti, V., Cartia, C. S., Ganzetti, M., Benveuti, P., Pompa, A., Catalano, M., Fugazza, E., Landini, B., Arcaini, L. & Corso, A., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Multiple Myeloma
Bone Marrow
Light
Plasma Cells
Serum
2018

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D'Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Oct 23 2018, In : Annals of Hematology.

Research output: Contribution to journalArticle

Salvage Therapy
Multiple Myeloma
Therapeutics
Recurrence
Drug Combinations

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D’Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Jan 1 2018, (Accepted/In press) In : Annals of Hematology.

Research output: Contribution to journalArticle

Salvage Therapy
Multiple Myeloma
Therapeutics
Recurrence
Drug Combinations
6 Citations (Scopus)

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

EMMOS Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Stem Cell Transplantation
Thalidomide
Cell Transplantation
Therapeutics

The advantages of switch to subcutaneous bortezomib in the real life

Mangiacavalli, S., Cocito, F., Ferretti, V. V., Ganzetti, M., Cartia, C. S. & Corso, A., Jun 2018, In : Leukemia and Lymphoma. 59, 6, p. 1505-1507 3 p.

Research output: Contribution to journalArticle

2017
3 Citations (Scopus)

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Mar 1 2017, In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents
10 Citations (Scopus)

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial

Bahlis, N. J., Corso, A., Mugge, L. O., Shen, Z. X., Desjardins, P., Stoppa, A. M., Decaux, O., De Revel, T., Granell, M., Marit, G., Nahi, H., Demuynck, H., Huang, S. Y., Basu, S., Guthrie, T. H., Ervin-Haynes, A., Marek, J., Chen, G. & Facon, T., Nov 1 2017, In : Leukemia. 31, 11, p. 2435-2442 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Thalidomide
Therapeutics
Dexamethasone
Melphalan
17 Citations (Scopus)

The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity

Oliva, L., Orfanelli, U., Resnati, M., Raimondi, A., Orsi, A., Milan, E., Palladini, G., Milani, P., Cerruti, F., Cascio, P., Casarini, S., Rognoni, P., Touvier, T., Marcatti, M., Ciceri, F., Mangiacavalli, S., Corso, A., Merlini, G. & Cenci, S., Apr 13 2017, In : Blood. 129, 15, p. 2132-2142 11 p.

Research output: Contribution to journalArticle

Proteasome Inhibitors
Plasma Cells
Toxicity
Plasmas
Light
17 Citations (Scopus)

The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity

Oliva, L., Orfanelli, U., Resnati, M., Raimondi, A., Orsi, A., Milan, E., Palladini, G., Milani, P., Cerruti, F., Cascio, P., Casarini, S., Rognoni, P., Touvier, T., Marcatti, M., Ciceri, F., Mangiacavalli, S., Corso, A., Merlini, G. & Cenci, S., 2017, In : Blood. 129, 15, p. 2132-2142 11 p.

Research output: Contribution to journalArticle

Proteasome Inhibitors
Plasma Cells
Toxicity
Plasmas
Light
8 Citations (Scopus)

The possible role of burden of therapy on the risk of myeloma extramedullary spread

Mangiacavalli, S., Pompa, A., Ferretti, V., Klersy, C., Cocito, F., Varettoni, M., Cartia, C. S., Cazzola, M. & Corso, A., Jan 1 2017, In : Annals of Hematology. 96, 1, p. 73-80 8 p.

Research output: Contribution to journalArticle

Recurrence
Therapeutics
Multiple Myeloma
Cohort Studies
Multivariate Analysis
2016
3 Citations (Scopus)

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S. S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, G. A. & Morabito, F., Dec 6 2016, In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S. S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents
21 Citations (Scopus)

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice

Jurczyszyn, A., Grzasko, N., Gozzetti, A., Czepiel, J., Cerase, A., Hungria, V., Crusoe, E., Silva Dias, A. L. M., Vij, R., Fiala, M. A., Caers, J., Rasche, L., Nooka, A. K., Lonial, S., Vesole, D. H., Philip, S., Gangatharan, S., Druzd-Sitek, A., Walewski, J., Corso, A. & 31 others, Cocito, F., Vekemans, M. C. M., Atilla, E., Beksac, M., Leleu, X., Davila, J., Badros, A., Aneja, E., Abildgaard, N., Kastritis, E., Fantl, D., Schutz, N., Pika, T., Butrym, A., Olszewska-Szopa, M., Usnarska-Zubkiewicz, L., Usmani, S. Z., Nahi, H., Chim, C. S., Shustik, C., Madry, K., Lentzsch, S., Swiderska, A., Helbig, G., Guzicka-Kazimierczak, R., Lendvai, N., Waage, A., Andersen, K. T., Murakami, H., Zweegman, S. & Castillo, J. J., Jun 1 2016, In : American Journal of Hematology. 91, 6, p. 575-580 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Central Nervous System
Retrospective Studies
Survival
Radiotherapy
5 Citations (Scopus)

Implemented myeloma management with whole-body low-dose CT scan: a real life experience

Mangiacavalli, S., Pezzatti, S., Rossini, F., Doni, E., Cocito, F., Bolis, S. & Corso, A., Jan 20 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

Life Change Events
Incidental Findings
Bone and Bones
Plasmacytoma
Hypercalcemia
8 Citations (Scopus)

The possible role of burden of therapy on the risk of myeloma extramedullary spread

Mangiacavalli, S., Pompa, A., Ferretti, V., Klersy, C., Cocito, F., Varettoni, M., Cartia, C. S., Cazzola, M. & Corso, A., Oct 21 2016, (Accepted/In press) In : Annals of Hematology. p. 1-8 8 p.

Research output: Contribution to journalArticle

Recurrence
Therapeutics
Multiple Myeloma
Cohort Studies
Multivariate Analysis
2015
7 Citations (Scopus)

Efficacy and safety of bortezomib-based retreatment at the first relapse in multiple myeloma patients: A retrospective study

Oriol, A., Giraldo, P., Kotsianidis, I., Couturier, C., Olie, R., Angermund, R. & Corso, A., Aug 1 2015, In : Hematology. 20, 7, p. 405-409 5 p.

Research output: Contribution to journalArticle

Retreatment
Multiple Myeloma
Retrospective Studies
Safety
Recurrence
3 Citations (Scopus)

Inter-observer agreement for the evaluation of bone involvement on Whole Body Low Dose Computed Tomography (WBLDCT) in Multiple Myeloma (MM)

Zacchino, M., Bonaffini, P. A., Corso, A., Minetti, V., Nasatti, A., Tinelli, C., Dore, R., Calliada, F. & Sironi, S., Nov 1 2015, In : European Radiology. 25, 11, p. 3382-3389 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Tomography
Bone and Bones
Bone Diseases
24 Citations (Scopus)

Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents

Romano, A., Parrinello, N. L., Consoli, M. L., Marchionni, L., Forte, S., Conticello, C., Pompa, A., Corso, A., Milone, G., Di Raimondo, F. & Borrello, I., Nov 22 2015, In : Annals of Hematology. 94, 11, p. 1875-1883 9 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Neutrophils
Lymphocytes
Disease-Free Survival
Survival
2 Citations (Scopus)
2014

Correction: Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: A cost-effectiveness analysis (PLoS ONE)

Corso, A., Mangiacavalli, S., Cocito, F., Pascutto, C., Ferretti, V. V., Pompa, A., Ciampichini, R., Pochintesta, L. & Mantovani, L. G., Jan 8 2014, In : PLoS One. 9, 1

Research output: Contribution to journalArticle

7 Citations (Scopus)

Psychological care of caregivers, nurses and physicians: a study of a new approach

Abeni, M. S., Magni, M., Conte, M., Mangiacavalli, S., Pochintesta, L., Vicenzi, G., Ferretti, V. V., Pompa, A., Cocito, F., Klersy, C. & Corso, A., Feb 1 2014, In : Cancer Medicine. 3, 1, p. 101-110 10 p.

Research output: Contribution to journalArticle

Caregivers
Nurses
Psychology
Physicians
Defense Mechanisms
2013
7 Citations (Scopus)
3 Citations (Scopus)
fotemustine
Multiple Myeloma
Dexamethasone
Alkylating Agents
Disease-Free Survival
9 Citations (Scopus)

Long Term Evaluation of the Impact of Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: A Cost-Effectiveness Analysis

Corso, A., Mangiacavalli, S., Cocito, F., Pascutto, C., Ferretti, V. V., Pompa, A., Ciampichini, R., Pochintesta, L. & Mantovani, L. G., Sep 30 2013, In : PLoS One. 8, 9, e75047.

Research output: Contribution to journalArticle

Peripheral Blood Stem Cell Transplantation
cell transplantation
myeloma
cost effectiveness
Cost effectiveness
17 Citations (Scopus)

Monoclonal gammopathy of undetermined significance: A new proposal of workup

Mangiacavalli, S., Cocito, F., Pochintesta, L., Pascutto, C., Ferretti, V., Varettoni, M., Zappasodi, P., Pompa, A., Landini, B., Cazzola, M. & Corso, A., Oct 2013, In : European Journal of Haematology. 91, 4, p. 356-360 5 p.

Research output: Contribution to journalArticle

Monoclonal Gammopathy of Undetermined Significance
Multiple Myeloma
Hematology
Plasma Cells
Bone Marrow Cells
179 Citations (Scopus)
Waldenstrom Macroglobulinemia
Monoclonal Gammopathy of Undetermined Significance
Immunoglobulin M
Mutation
Neoplasms
2012
521 Citations (Scopus)

Continuous lenalidomide treatment for newly diagnosed multiple myeloma

Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jȩdrzejczak, W., Zodelava, M., Weisel, K., Cascavilla, N., Iosava, G., Cavo, M., Kloczko, J., Bladé, J., Beksac, M., Spicka, I., Plesner, T., Radke, J., Langer, C. & 7 others, Yehuda, D. B., Corso, A., Herbein, L., Yu, Z., Mei, J., Jacques, C. & Dimopoulos, M. A., May 10 2012, In : New England Journal of Medicine. 366, 19, p. 1759-1769 11 p.

Research output: Contribution to journalArticle

Melphalan
Multiple Myeloma
Prednisone
Therapeutics
Disease-Free Survival
7 Citations (Scopus)
Multiple Myeloma
Disease-Free Survival
Transplants
Autografts
Proportional Hazards Models
27 Citations (Scopus)

Risk of second cancers in Waldenström macroglobulinemia

Varettoni, M., Tedeschi, A., Arcaini, L., Pascutto, C., Vismara, E., Orlandi, E., Ricci, F., Corso, A., Greco, A., Mangiacavalli, S., Lazzarino, M. & Morra, E., Feb 2012, In : Annals of Oncology. 23, 2, p. 411-415 5 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Second Primary Neoplasms
Incidence
Hematologic Neoplasms
Lymphoproliferative Disorders
1 Citation (Scopus)

Similar neurotoxicity of an alternating compared to a continuous low-dose schedule of thalidomide for relapsed/refractory multiple myeloma

Mangiacavalli, S., Albani, G., Caravita, T., Cocito, F., Pascutto, C., Zappasodi, P., Bringhen, S., Palumbo, A., Cazzola, M. & Corso, A., Mar 2012, In : Leukemia and Lymphoma. 53, 3, p. 514-515 2 p.

Research output: Contribution to journalArticle

2010
105 Citations (Scopus)

Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma

Harousseau, J. L., Dimopoulos, M. A., Wang, M., Corso, A., Chen, C., Attal, M., Spencer, A., Yu, Z., Olesnyckyj, M., Zeldis, J. B., Knight, R. D. & Weber, D. M., Oct 2010, In : Haematologica. 95, 10, p. 1738-1744 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Survival
lenalidomide
Reaction Time
58 Citations (Scopus)
Peripheral Nervous System Diseases
Multiple Myeloma
Neuralgia
Incidence
Bortezomib
14 Citations (Scopus)

Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma

Corso, A., Barbarano, L., Mangiacavalli, S., Spriano, M., Alessandrino, E. P., Cafro, A. M., Pascutto, C., Varettoni, M., Bernasconi, P., Grillo, G., Carella, A. M., Montalbetti, L., Lazzarino, M. & Morra, E., Feb 2010, In : Leukemia and Lymphoma. 51, 2, p. 236-242 7 p.

Research output: Contribution to journalArticle

Autografts
Dexamethasone
Stem Cells
Drug Therapy
Etoposide
13 Citations (Scopus)

Changing pattern of presentation in monoclonal gammopathy of undetermined significance: A single-center experience with 1400 patients

Varettoni, M., Corso, A., Cocito, F., Mangiacavalli, S., Pascutto, C., Zappasodi, P., Pica, G. & Lazzarino, M., Jul 2010, In : Medicine (United States). 89, 4, p. 211-216 6 p.

Research output: Contribution to journalArticle

Monoclonal Gammopathy of Undetermined Significance
Plasma Cells
Bone Marrow Cells
Immunoglobulin M
Albumins
224 Citations (Scopus)

Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: A longitudinal study on 1003 consecutive patients

Varettoni, M., Corso, A., Pica, G., Mangiacavalli, S., Pascutto, C. & Lazzarino, M., Feb 2010, In : Annals of Oncology. 21, 2, p. 325-330 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Longitudinal Studies
Incidence
Therapeutics
Thalidomide
2009
3 Citations (Scopus)

A striking response to bortezomib in a patient with pleural localization of multiple myeloma

Mangiacavalli, S., Varettoni, M., Zappasodi, P., Pica, G., Lazzarino, M. & Corso, A., Apr 2009, In : Leukemia Research. 33, 4, p. 577-578 2 p.

Research output: Contribution to journalArticle

14 Citations (Scopus)

Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-lived

Corso, A., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Pica, G. M., Algarotti, A., Pascutto, C. & Lazzarino, M., Nov 2009, In : European Journal of Haematology. 83, 5, p. 449-454 6 p.

Research output: Contribution to journalArticle

Dexamethasone
Peripheral Nervous System Diseases
Multiple Myeloma
Bortezomib
Therapeutics
16 Citations (Scopus)

Considerations in the treatment of multiple myeloma: A consensus statement from Italian experts

Patriarca, F., Petrucci, M. T., Bringhen, S., Baldini, L., Caravita, T., Corradini, P., Corso, A., Di Raimondo, F., Falcone, A., Ferrara, F., Morabito, F., Musto, P., Offidani, M., Petrini, M., Rizzi, R., Semenzato, G., Tosi, P., Vacca, A., Cavo, M., Boccadoro, M. & 1 others, Palumbo, A., Feb 2009, In : European Journal of Haematology. 82, 2, p. 93-105 13 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Stem Cell Transplantation
Thalidomide
Therapeutics
Transplants
5 Citations (Scopus)

Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients

Mangiacavalli, S., Pica, G., Varettoni, M., Lazzarino, M. & Corso, A., Mar 2009, In : European Journal of Haematology. 82, 3, p. 240-241 2 p.

Research output: Contribution to journalArticle

89 Citations (Scopus)

High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: Results of a global phase 3b expanded access program

Mikhael, J. R., Belch, A. R., Prince, H. M., Lucio, M. N., Maiolino, A., Corso, A., Petrucci, M. T., Musto, P., Komarnicki, M. & Stewart, A. K., Jan 2009, In : British Journal of Haematology. 144, 2, p. 169-175 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Peripheral Nervous System Diseases
Neutropenia
Thrombocytopenia